Mechanisms of Disease: Pathogenesis of Crohn's Disease and Ulcerative Colitis
The review brings together evidence that genetics, immune responses, the gut microbiome, and environmental triggers interact to cause Crohn's disease and ulcerative colitis.
Understanding these mechanisms can help explain why patients respond differently to treatments and may guide future diagnostic and therapeutic strategies.
Clinicians and researchers working on IBD, adult patients and newly diagnosed people seeking mechanistic context, and caregivers interested in disease causes.
What To Know
This Medscape review summarizes current ideas about what causes Crohn's disease and ulcerative colitis — focusing on genetics, immune-system responses, the gut microbiome, and environmental triggers — which helps explain why disease courses and treatment responses vary between people.
This article reviews evidence that Crohn's disease and ulcerative colitis are heterogeneous, immune-mediated conditions in which genetic differences can lead to defects in mucosal barrier function, immune regulation, or bacterial clearance.
It emphasizes interactions among host genes, commensal gut bacteria, and environmental factors (for example, things that alter the mucosal barrier or the microbiome) as contributors to disease onset and flares.
The review discusses how overly aggressive T-cell responses to certain gut bacteria in genetically susceptible people likely drive chronic inflammation, and it highlights that different genetic abnormalities can produce similar clinical disease patterns.
The author also notes the potential to develop more precise diagnostic approaches that identify patient subsets with predictable disease courses or treatment responses.
Clinicians and researchers following IBD pathogenesis, adult patients and newly diagnosed people who want a deeper, mechanistic overview, and caregivers interested in underlying causes rather than immediate treatment changes. This is a narrative review summarizing findings from animal models, genetics, basic science, and clinical studies.
It is not a clinical guideline and does not provide treatment recommendations; it aims to synthesize hypotheses and evidence about disease mechanisms. Summary confidence: medium.
This is a Medscape review synthesizing animal, genetic, basic science, and clinical-trial evidence. It summarizes hypotheses about pathogenesis rather than reporting a single new trial or clinical recommendation.